Status:
COMPLETED
Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health
Lead Sponsor:
University of Central Florida
Conditions:
Gastrointestinal Disease
Gastrointestinal Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gas...
Detailed Description
Disorders of gut-brain interactions (DGBI) (also known as functional gastrointestinal disorders (FGID)) are defined as distinct combinations of chronic or recurrent gastrointestinal symptoms, with no ...
Eligibility Criteria
Inclusion
- 18 years or older
- Self reported gastrointestinal symptoms consistent with disorders of gut-brain interaction
- English speaking
- Willingness to participate in all hypnotherapy sessions \& complete all pre- and post-session surveys
Exclusion
- Under 18 years
- Pregnant women
- Prisoners
- Children
- Individuals with active or a history of severe mental illness (e.g. active psychosis, dissociative disorders)
- A hypnotic susceptibility score in the low range (SHSS; total = 0-3)
Key Trial Info
Start Date :
March 19 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2025
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06890663
Start Date
March 19 2025
End Date
October 30 2025
Last Update
November 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Central Florida
Orlando, Florida, United States, 32816